{
  "ticker": "ABBV",
  "year": 2023,
  "quarter": 1,
  "last_updated": "2025-04-15T15:30:14.989776",
  "count": 81,
  "transactions": [
    {
      "id": 71094,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Stewart Jeffrey Ryan",
      "reporting_owner_cik": "0001761675",
      "reporting_owner_position": "EVP, CHIEF COMMERCIAL OFFICER",
      "transaction_date": "2023-03-13",
      "transaction_shares": "21810",
      "transaction_price": "54.86",
      "transaction_type": "M",
      "shares_after_transaction": "114066"
    },
    {
      "id": 111675,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Stewart Jeffrey Ryan",
      "reporting_owner_cik": "0001761675",
      "reporting_owner_position": "EVP, CHIEF COMMERCIAL OFFICER",
      "transaction_date": "2023-03-13",
      "transaction_shares": "21810",
      "transaction_price": "54.86",
      "transaction_type": "M",
      "shares_after_transaction": "114066"
    },
    {
      "id": 158498,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Stewart Jeffrey Ryan",
      "reporting_owner_cik": "0001761675",
      "reporting_owner_position": "EVP, CHIEF COMMERCIAL OFFICER",
      "transaction_date": "2023-03-13",
      "transaction_shares": "21810",
      "transaction_price": "54.86",
      "transaction_type": "M",
      "shares_after_transaction": "114066"
    },
    {
      "id": 71114,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Strom Carrie C",
      "reporting_owner_cik": "0001811896",
      "reporting_owner_position": "SVP & PRES GLOBAL ALLERG AESTH",
      "transaction_date": "2023-03-05",
      "transaction_shares": "449",
      "transaction_price": "156.06",
      "transaction_type": "F",
      "shares_after_transaction": "30900"
    },
    {
      "id": 111698,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Strom Carrie C",
      "reporting_owner_cik": "0001811896",
      "reporting_owner_position": "SVP & PRES GLOBAL ALLERG AESTH",
      "transaction_date": "2023-03-05",
      "transaction_shares": "449",
      "transaction_price": "156.06",
      "transaction_type": "F",
      "shares_after_transaction": "30900"
    },
    {
      "id": 158522,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Strom Carrie C",
      "reporting_owner_cik": "0001811896",
      "reporting_owner_position": "SVP & PRES GLOBAL ALLERG AESTH",
      "transaction_date": "2023-03-05",
      "transaction_shares": "449",
      "transaction_price": "156.06",
      "transaction_type": "F",
      "shares_after_transaction": "30900"
    },
    {
      "id": 71067,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "GONZALEZ RICHARD A",
      "reporting_owner_cik": "0001239127",
      "reporting_owner_position": "CHAIRMAN OF THE BOARD AND CEO",
      "transaction_date": "2023-03-03",
      "transaction_shares": "2550",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "643794"
    },
    {
      "id": 111640,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "GONZALEZ RICHARD A",
      "reporting_owner_cik": "0001239127",
      "reporting_owner_position": "CHAIRMAN OF THE BOARD AND CEO",
      "transaction_date": "2023-03-03",
      "transaction_shares": "2550",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "643794"
    },
    {
      "id": 158459,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "GONZALEZ RICHARD A",
      "reporting_owner_cik": "0001239127",
      "reporting_owner_position": "CHAIRMAN OF THE BOARD AND CEO",
      "transaction_date": "2023-03-03",
      "transaction_shares": "2550",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "643794"
    },
    {
      "id": 71062,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Strom Carrie C",
      "reporting_owner_cik": "0001811896",
      "reporting_owner_position": "SVP & PRES GLOBAL ALLERG AESTH",
      "transaction_date": "2023-02-28",
      "transaction_shares": "5762",
      "transaction_price": "154.28",
      "transaction_type": "F",
      "shares_after_transaction": "32159"
    },
    {
      "id": 71070,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Hudson Thomas J",
      "reporting_owner_cik": "0001781947",
      "reporting_owner_position": "SVP, R&D AND CSO",
      "transaction_date": "2023-02-28",
      "transaction_shares": "27922",
      "transaction_price": "154.28",
      "transaction_type": "F",
      "shares_after_transaction": "81329"
    },
    {
      "id": 71073,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Michael Robert A.",
      "reporting_owner_cik": "0001699914",
      "reporting_owner_position": "VICE CHAIRMAN",
      "transaction_date": "2023-02-28",
      "transaction_shares": "48335",
      "transaction_price": "154.28",
      "transaction_type": "F",
      "shares_after_transaction": "98645"
    },
    {
      "id": 71077,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "RICHMOND TIMOTHY J.",
      "reporting_owner_cik": "0001563523",
      "reporting_owner_position": "EVP, CHIEF HR OFFICER",
      "transaction_date": "2023-02-28",
      "transaction_shares": "35111",
      "transaction_price": "154.28",
      "transaction_type": "F",
      "shares_after_transaction": "57978"
    },
    {
      "id": 71078,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Sorg Elaine K.",
      "reporting_owner_cik": "0001832571",
      "reporting_owner_position": "SVP, US COMMERCIAL OPERATIONS",
      "transaction_date": "2023-02-28",
      "transaction_shares": "19850",
      "transaction_price": "154.28",
      "transaction_type": "F",
      "shares_after_transaction": "42829"
    },
    {
      "id": 71085,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "SALEKI-GERHARDT AZITA",
      "reporting_owner_cik": "0001563545",
      "reporting_owner_position": "EVP, OPERATIONS",
      "transaction_date": "2023-02-28",
      "transaction_shares": "33359",
      "transaction_price": "154.28",
      "transaction_type": "F",
      "shares_after_transaction": "199849"
    },
    {
      "id": 71086,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Stewart Jeffrey Ryan",
      "reporting_owner_cik": "0001761675",
      "reporting_owner_position": "EVP, COMMERCIAL OPERATIONS",
      "transaction_date": "2023-02-28",
      "transaction_shares": "24910",
      "transaction_price": "154.28",
      "transaction_type": "F",
      "shares_after_transaction": "92256"
    },
    {
      "id": 71089,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Reents Scott T",
      "reporting_owner_cik": "0001937048",
      "reporting_owner_position": "EVP, CHIEF FINANCIAL OFFICER",
      "transaction_date": "2023-02-28",
      "transaction_shares": "12683",
      "transaction_price": "154.28",
      "transaction_type": "F",
      "shares_after_transaction": "16751"
    },
    {
      "id": 71091,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Durkin Brian L",
      "reporting_owner_cik": "0001756865",
      "reporting_owner_position": "VP, CONTROLLER",
      "transaction_date": "2023-02-28",
      "transaction_shares": "11182",
      "transaction_price": "154.28",
      "transaction_type": "F",
      "shares_after_transaction": "33149"
    },
    {
      "id": 71109,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Siatis Perry C",
      "reporting_owner_cik": "0001951400",
      "reporting_owner_position": "EVP, GC AND SECRETARY",
      "transaction_date": "2023-02-28",
      "transaction_shares": "9656",
      "transaction_price": "154.28",
      "transaction_type": "F",
      "shares_after_transaction": "22512"
    },
    {
      "id": 71110,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "GONZALEZ RICHARD A",
      "reporting_owner_cik": "0001239127",
      "reporting_owner_position": "CHAIRMAN OF THE BOARD AND CEO",
      "transaction_date": "2023-02-28",
      "transaction_shares": "113810",
      "transaction_price": "154.28",
      "transaction_type": "F",
      "shares_after_transaction": "646344"
    },
    {
      "id": 111632,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Strom Carrie C",
      "reporting_owner_cik": "0001811896",
      "reporting_owner_position": "SVP & PRES GLOBAL ALLERG AESTH",
      "transaction_date": "2023-02-28",
      "transaction_shares": "5762",
      "transaction_price": "154.28",
      "transaction_type": "F",
      "shares_after_transaction": "32159"
    },
    {
      "id": 111643,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Hudson Thomas J",
      "reporting_owner_cik": "0001781947",
      "reporting_owner_position": "SVP, R&D AND CSO",
      "transaction_date": "2023-02-28",
      "transaction_shares": "27922",
      "transaction_price": "154.28",
      "transaction_type": "F",
      "shares_after_transaction": "81329"
    },
    {
      "id": 111646,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Michael Robert A.",
      "reporting_owner_cik": "0001699914",
      "reporting_owner_position": "VICE CHAIRMAN",
      "transaction_date": "2023-02-28",
      "transaction_shares": "48335",
      "transaction_price": "154.28",
      "transaction_type": "F",
      "shares_after_transaction": "98645"
    },
    {
      "id": 111651,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "RICHMOND TIMOTHY J.",
      "reporting_owner_cik": "0001563523",
      "reporting_owner_position": "EVP, CHIEF HR OFFICER",
      "transaction_date": "2023-02-28",
      "transaction_shares": "35111",
      "transaction_price": "154.28",
      "transaction_type": "F",
      "shares_after_transaction": "57978"
    },
    {
      "id": 111652,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Sorg Elaine K.",
      "reporting_owner_cik": "0001832571",
      "reporting_owner_position": "SVP, US COMMERCIAL OPERATIONS",
      "transaction_date": "2023-02-28",
      "transaction_shares": "19850",
      "transaction_price": "154.28",
      "transaction_type": "F",
      "shares_after_transaction": "42829"
    },
    {
      "id": 111660,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "SALEKI-GERHARDT AZITA",
      "reporting_owner_cik": "0001563545",
      "reporting_owner_position": "EVP, OPERATIONS",
      "transaction_date": "2023-02-28",
      "transaction_shares": "33359",
      "transaction_price": "154.28",
      "transaction_type": "F",
      "shares_after_transaction": "199849"
    },
    {
      "id": 111663,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Stewart Jeffrey Ryan",
      "reporting_owner_cik": "0001761675",
      "reporting_owner_position": "EVP, COMMERCIAL OPERATIONS",
      "transaction_date": "2023-02-28",
      "transaction_shares": "24910",
      "transaction_price": "154.28",
      "transaction_type": "F",
      "shares_after_transaction": "92256"
    },
    {
      "id": 111666,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Reents Scott T",
      "reporting_owner_cik": "0001937048",
      "reporting_owner_position": "EVP, CHIEF FINANCIAL OFFICER",
      "transaction_date": "2023-02-28",
      "transaction_shares": "12683",
      "transaction_price": "154.28",
      "transaction_type": "F",
      "shares_after_transaction": "16751"
    },
    {
      "id": 111671,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Durkin Brian L",
      "reporting_owner_cik": "0001756865",
      "reporting_owner_position": "VP, CONTROLLER",
      "transaction_date": "2023-02-28",
      "transaction_shares": "11182",
      "transaction_price": "154.28",
      "transaction_type": "F",
      "shares_after_transaction": "33149"
    },
    {
      "id": 111693,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Siatis Perry C",
      "reporting_owner_cik": "0001951400",
      "reporting_owner_position": "EVP, GC AND SECRETARY",
      "transaction_date": "2023-02-28",
      "transaction_shares": "9656",
      "transaction_price": "154.28",
      "transaction_type": "F",
      "shares_after_transaction": "22512"
    },
    {
      "id": 111694,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "GONZALEZ RICHARD A",
      "reporting_owner_cik": "0001239127",
      "reporting_owner_position": "CHAIRMAN OF THE BOARD AND CEO",
      "transaction_date": "2023-02-28",
      "transaction_shares": "113810",
      "transaction_price": "154.28",
      "transaction_type": "F",
      "shares_after_transaction": "646344"
    },
    {
      "id": 158451,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Strom Carrie C",
      "reporting_owner_cik": "0001811896",
      "reporting_owner_position": "SVP & PRES GLOBAL ALLERG AESTH",
      "transaction_date": "2023-02-28",
      "transaction_shares": "5762",
      "transaction_price": "154.28",
      "transaction_type": "F",
      "shares_after_transaction": "32159"
    },
    {
      "id": 158462,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Hudson Thomas J",
      "reporting_owner_cik": "0001781947",
      "reporting_owner_position": "SVP, R&D AND CSO",
      "transaction_date": "2023-02-28",
      "transaction_shares": "27922",
      "transaction_price": "154.28",
      "transaction_type": "F",
      "shares_after_transaction": "81329"
    },
    {
      "id": 158466,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Michael Robert A.",
      "reporting_owner_cik": "0001699914",
      "reporting_owner_position": "VICE CHAIRMAN",
      "transaction_date": "2023-02-28",
      "transaction_shares": "48335",
      "transaction_price": "154.28",
      "transaction_type": "F",
      "shares_after_transaction": "98645"
    },
    {
      "id": 158473,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "RICHMOND TIMOTHY J.",
      "reporting_owner_cik": "0001563523",
      "reporting_owner_position": "EVP, CHIEF HR OFFICER",
      "transaction_date": "2023-02-28",
      "transaction_shares": "35111",
      "transaction_price": "154.28",
      "transaction_type": "F",
      "shares_after_transaction": "57978"
    },
    {
      "id": 158474,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Sorg Elaine K.",
      "reporting_owner_cik": "0001832571",
      "reporting_owner_position": "SVP, US COMMERCIAL OPERATIONS",
      "transaction_date": "2023-02-28",
      "transaction_shares": "19850",
      "transaction_price": "154.28",
      "transaction_type": "F",
      "shares_after_transaction": "42829"
    },
    {
      "id": 158482,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "SALEKI-GERHARDT AZITA",
      "reporting_owner_cik": "0001563545",
      "reporting_owner_position": "EVP, OPERATIONS",
      "transaction_date": "2023-02-28",
      "transaction_shares": "33359",
      "transaction_price": "154.28",
      "transaction_type": "F",
      "shares_after_transaction": "199849"
    },
    {
      "id": 158486,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Stewart Jeffrey Ryan",
      "reporting_owner_cik": "0001761675",
      "reporting_owner_position": "EVP, COMMERCIAL OPERATIONS",
      "transaction_date": "2023-02-28",
      "transaction_shares": "24910",
      "transaction_price": "154.28",
      "transaction_type": "F",
      "shares_after_transaction": "92256"
    },
    {
      "id": 158489,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Reents Scott T",
      "reporting_owner_cik": "0001937048",
      "reporting_owner_position": "EVP, CHIEF FINANCIAL OFFICER",
      "transaction_date": "2023-02-28",
      "transaction_shares": "12683",
      "transaction_price": "154.28",
      "transaction_type": "F",
      "shares_after_transaction": "16751"
    },
    {
      "id": 158494,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Durkin Brian L",
      "reporting_owner_cik": "0001756865",
      "reporting_owner_position": "VP, CONTROLLER",
      "transaction_date": "2023-02-28",
      "transaction_shares": "11182",
      "transaction_price": "154.28",
      "transaction_type": "F",
      "shares_after_transaction": "33149"
    },
    {
      "id": 158516,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Siatis Perry C",
      "reporting_owner_cik": "0001951400",
      "reporting_owner_position": "EVP, GC AND SECRETARY",
      "transaction_date": "2023-02-28",
      "transaction_shares": "9656",
      "transaction_price": "154.28",
      "transaction_type": "F",
      "shares_after_transaction": "22512"
    },
    {
      "id": 158517,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "GONZALEZ RICHARD A",
      "reporting_owner_cik": "0001239127",
      "reporting_owner_position": "CHAIRMAN OF THE BOARD AND CEO",
      "transaction_date": "2023-02-28",
      "transaction_shares": "113810",
      "transaction_price": "154.28",
      "transaction_type": "F",
      "shares_after_transaction": "646344"
    },
    {
      "id": 71068,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Siatis Perry C",
      "reporting_owner_cik": "0001951400",
      "reporting_owner_position": "EVP, GC AND SECRETARY",
      "transaction_date": "2023-02-21",
      "transaction_shares": "7364",
      "transaction_price": "93.50",
      "transaction_type": "M",
      "shares_after_transaction": "39532"
    },
    {
      "id": 111641,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Siatis Perry C",
      "reporting_owner_cik": "0001951400",
      "reporting_owner_position": "EVP, GC AND SECRETARY",
      "transaction_date": "2023-02-21",
      "transaction_shares": "7364",
      "transaction_price": "93.50",
      "transaction_type": "M",
      "shares_after_transaction": "39532"
    },
    {
      "id": 158460,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Siatis Perry C",
      "reporting_owner_cik": "0001951400",
      "reporting_owner_position": "EVP, GC AND SECRETARY",
      "transaction_date": "2023-02-21",
      "transaction_shares": "7364",
      "transaction_price": "93.50",
      "transaction_type": "M",
      "shares_after_transaction": "39532"
    },
    {
      "id": 71090,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "AUSTIN ROXANNE S",
      "reporting_owner_cik": "0001061632",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-17",
      "transaction_shares": "10000",
      "transaction_price": "150.50",
      "transaction_type": "S",
      "shares_after_transaction": "40705"
    },
    {
      "id": 111668,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "AUSTIN ROXANNE S",
      "reporting_owner_cik": "0001061632",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-17",
      "transaction_shares": "10000",
      "transaction_price": "150.50",
      "transaction_type": "S",
      "shares_after_transaction": "40705"
    },
    {
      "id": 158491,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "AUSTIN ROXANNE S",
      "reporting_owner_cik": "0001061632",
      "reporting_owner_position": null,
      "transaction_date": "2023-02-17",
      "transaction_shares": "10000",
      "transaction_price": "150.50",
      "transaction_type": "S",
      "shares_after_transaction": "40705"
    },
    {
      "id": 71065,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Reents Scott T",
      "reporting_owner_cik": "0001937048",
      "reporting_owner_position": "EVP, CHIEF FINANCIAL OFFICER",
      "transaction_date": "2023-02-16",
      "transaction_shares": "18715",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "19524"
    },
    {
      "id": 71066,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Hudson Thomas J",
      "reporting_owner_cik": "0001781947",
      "reporting_owner_position": "SVP, R&D AND CSO",
      "transaction_date": "2023-02-16",
      "transaction_shares": "40640",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "86868"
    },
    {
      "id": 71075,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Durkin Brian L",
      "reporting_owner_cik": "0001756865",
      "reporting_owner_position": "VP, CONTROLLER",
      "transaction_date": "2023-02-16",
      "transaction_shares": "16042",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "35136"
    },
    {
      "id": 71080,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Sorg Elaine K.",
      "reporting_owner_cik": "0001832571",
      "reporting_owner_position": "SVP, US COMMERCIAL OPERATIONS",
      "transaction_date": "2023-02-16",
      "transaction_shares": "29410",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "47286"
    },
    {
      "id": 71083,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Stewart Jeffrey Ryan",
      "reporting_owner_cik": "0001761675",
      "reporting_owner_position": "EVP, COMMERCIAL OPERATIONS",
      "transaction_date": "2023-02-16",
      "transaction_shares": "32085",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "93026"
    },
    {
      "id": 71088,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Michael Robert A.",
      "reporting_owner_cik": "0001699914",
      "reporting_owner_position": "VICE CHAIRMAN",
      "transaction_date": "2023-02-16",
      "transaction_shares": "69517",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "107394"
    },
    {
      "id": 71095,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "RICHMOND TIMOTHY J.",
      "reporting_owner_cik": "0001563523",
      "reporting_owner_position": "EVP, CHIEF HR OFFICER",
      "transaction_date": "2023-02-16",
      "transaction_shares": "51335",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "65172"
    },
    {
      "id": 71096,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Strom Carrie C",
      "reporting_owner_cik": "0001811896",
      "reporting_owner_position": "SVP & PRES GLOBAL ALLERG AESTH",
      "transaction_date": "2023-02-16",
      "transaction_shares": "6546",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "47209"
    },
    {
      "id": 71101,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Siatis Perry C",
      "reporting_owner_cik": "0001951400",
      "reporting_owner_position": "EVP, GC AND SECRETARY",
      "transaction_date": "2023-02-16",
      "transaction_shares": "14437",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "24814"
    },
    {
      "id": 71103,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "GONZALEZ RICHARD A",
      "reporting_owner_cik": "0001239127",
      "reporting_owner_position": "CHAIRMAN OF THE BOARD AND CEO",
      "transaction_date": "2023-02-16",
      "transaction_shares": "149732",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "652985"
    },
    {
      "id": 71104,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "SALEKI-GERHARDT AZITA",
      "reporting_owner_cik": "0001563545",
      "reporting_owner_position": "EVP, OPERATIONS",
      "transaction_date": "2023-02-16",
      "transaction_shares": "48127",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "206039"
    },
    {
      "id": 111637,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Reents Scott T",
      "reporting_owner_cik": "0001937048",
      "reporting_owner_position": "EVP, CHIEF FINANCIAL OFFICER",
      "transaction_date": "2023-02-16",
      "transaction_shares": "18715",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "19524"
    },
    {
      "id": 111638,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Hudson Thomas J",
      "reporting_owner_cik": "0001781947",
      "reporting_owner_position": "SVP, R&D AND CSO",
      "transaction_date": "2023-02-16",
      "transaction_shares": "40640",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "86868"
    },
    {
      "id": 111648,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Durkin Brian L",
      "reporting_owner_cik": "0001756865",
      "reporting_owner_position": "VP, CONTROLLER",
      "transaction_date": "2023-02-16",
      "transaction_shares": "16042",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "35136"
    },
    {
      "id": 111654,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Sorg Elaine K.",
      "reporting_owner_cik": "0001832571",
      "reporting_owner_position": "SVP, US COMMERCIAL OPERATIONS",
      "transaction_date": "2023-02-16",
      "transaction_shares": "29410",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "47286"
    },
    {
      "id": 111657,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Stewart Jeffrey Ryan",
      "reporting_owner_cik": "0001761675",
      "reporting_owner_position": "EVP, COMMERCIAL OPERATIONS",
      "transaction_date": "2023-02-16",
      "transaction_shares": "32085",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "93026"
    },
    {
      "id": 111665,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Michael Robert A.",
      "reporting_owner_cik": "0001699914",
      "reporting_owner_position": "VICE CHAIRMAN",
      "transaction_date": "2023-02-16",
      "transaction_shares": "69517",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "107394"
    },
    {
      "id": 111676,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "RICHMOND TIMOTHY J.",
      "reporting_owner_cik": "0001563523",
      "reporting_owner_position": "EVP, CHIEF HR OFFICER",
      "transaction_date": "2023-02-16",
      "transaction_shares": "51335",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "65172"
    },
    {
      "id": 111677,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Strom Carrie C",
      "reporting_owner_cik": "0001811896",
      "reporting_owner_position": "SVP & PRES GLOBAL ALLERG AESTH",
      "transaction_date": "2023-02-16",
      "transaction_shares": "6546",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "47209"
    },
    {
      "id": 111685,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Siatis Perry C",
      "reporting_owner_cik": "0001951400",
      "reporting_owner_position": "EVP, GC AND SECRETARY",
      "transaction_date": "2023-02-16",
      "transaction_shares": "14437",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "24814"
    },
    {
      "id": 111687,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "GONZALEZ RICHARD A",
      "reporting_owner_cik": "0001239127",
      "reporting_owner_position": "CHAIRMAN OF THE BOARD AND CEO",
      "transaction_date": "2023-02-16",
      "transaction_shares": "149732",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "652985"
    },
    {
      "id": 111688,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "SALEKI-GERHARDT AZITA",
      "reporting_owner_cik": "0001563545",
      "reporting_owner_position": "EVP, OPERATIONS",
      "transaction_date": "2023-02-16",
      "transaction_shares": "48127",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "206039"
    },
    {
      "id": 158456,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Reents Scott T",
      "reporting_owner_cik": "0001937048",
      "reporting_owner_position": "EVP, CHIEF FINANCIAL OFFICER",
      "transaction_date": "2023-02-16",
      "transaction_shares": "18715",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "19524"
    },
    {
      "id": 158457,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Hudson Thomas J",
      "reporting_owner_cik": "0001781947",
      "reporting_owner_position": "SVP, R&D AND CSO",
      "transaction_date": "2023-02-16",
      "transaction_shares": "40640",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "86868"
    },
    {
      "id": 158468,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Durkin Brian L",
      "reporting_owner_cik": "0001756865",
      "reporting_owner_position": "VP, CONTROLLER",
      "transaction_date": "2023-02-16",
      "transaction_shares": "16042",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "35136"
    },
    {
      "id": 158476,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Sorg Elaine K.",
      "reporting_owner_cik": "0001832571",
      "reporting_owner_position": "SVP, US COMMERCIAL OPERATIONS",
      "transaction_date": "2023-02-16",
      "transaction_shares": "29410",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "47286"
    },
    {
      "id": 158479,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Stewart Jeffrey Ryan",
      "reporting_owner_cik": "0001761675",
      "reporting_owner_position": "EVP, COMMERCIAL OPERATIONS",
      "transaction_date": "2023-02-16",
      "transaction_shares": "32085",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "93026"
    },
    {
      "id": 158488,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Michael Robert A.",
      "reporting_owner_cik": "0001699914",
      "reporting_owner_position": "VICE CHAIRMAN",
      "transaction_date": "2023-02-16",
      "transaction_shares": "69517",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "107394"
    },
    {
      "id": 158499,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "RICHMOND TIMOTHY J.",
      "reporting_owner_cik": "0001563523",
      "reporting_owner_position": "EVP, CHIEF HR OFFICER",
      "transaction_date": "2023-02-16",
      "transaction_shares": "51335",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "65172"
    },
    {
      "id": 158500,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Strom Carrie C",
      "reporting_owner_cik": "0001811896",
      "reporting_owner_position": "SVP & PRES GLOBAL ALLERG AESTH",
      "transaction_date": "2023-02-16",
      "transaction_shares": "6546",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "47209"
    },
    {
      "id": 158508,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "Siatis Perry C",
      "reporting_owner_cik": "0001951400",
      "reporting_owner_position": "EVP, GC AND SECRETARY",
      "transaction_date": "2023-02-16",
      "transaction_shares": "14437",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "24814"
    },
    {
      "id": 158510,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "GONZALEZ RICHARD A",
      "reporting_owner_cik": "0001239127",
      "reporting_owner_position": "CHAIRMAN OF THE BOARD AND CEO",
      "transaction_date": "2023-02-16",
      "transaction_shares": "149732",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "652985"
    },
    {
      "id": 158511,
      "issuer_name": "AbbVie Inc.",
      "reporting_owner": "SALEKI-GERHARDT AZITA",
      "reporting_owner_cik": "0001563545",
      "reporting_owner_position": "EVP, OPERATIONS",
      "transaction_date": "2023-02-16",
      "transaction_shares": "48127",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "206039"
    }
  ]
}